| Gene Symbol | SLC39A11 |
|---|
| Alternative Names | ZIP11, Zrt- and Irt-like protein 11 |
|---|
| Full Name | Solute Carrier Family 39 Member 11 |
|---|
| Chromosomal Location | 17p13 |
|---|
| NCBI Gene ID | [201506](https://www.ncbi.nlm.nih.gov/gene/201506) |
|---|
| OMIM | 607345 |
|---|
| Ensembl | [ENSG00000133185](https://www.ensembl.org/Homo_sapiens/Gene?g=ENSG00000133185) |
|---|
| UniProt | [Q8N4W7](https://www.uniprot.org/uniprot/Q8N4W7) |
|---|
| Protein Class | Zinc transporter (ZIP family) |
|---|
| Expression | Testis, prostate, brain (lower), pancreas |
|---|
SLC39A11 (also known as ZIP11) is a member of the ZIP (Zrt-, Irt-like Protein) family of zinc transporters[@liuzzi2004]. These transporters are essential for cellular zinc homeostasis, facilitating zinc uptake into cells from the extracellular environment or from intracellular compartments. Zinc is an essential trace element critical for numerous biological processes, including enzyme catalysis, protein structure stabilization, transcriptional regulation, and synaptic signaling in the brain.
The ZIP family consists of 14 members (ZIP1-14) in humans, divided into four subfamilies based on phylogenetic analysis. ZIP11 belongs to the LIV-1 subfamily and is characterized by specific tissue distribution patterns and regulatory mechanisms. While ZIP11 expression is highest in reproductive tissues (testis and prostate), it is also expressed in various other tissues including the brain, where it may contribute to neuronal zinc homeostasis.
Zinc dysregulation has been implicated in multiple neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease[@dChart2011][@freitas2010]. Understanding the function of zinc transporters like ZIP11 provides insight into zinc homeostasis mechanisms and their potential role in neurodegeneration.
¶ Gene Structure and Protein Biology
The SLC39A11 gene is located on chromosome 17p13 and consists of 13 exons spanning approximately 25 kb. The gene encodes a 434-amino acid protein with a predicted molecular weight of approximately 47 kDa.
ZIP transporters share a common topology with 8 transmembrane domains (TMDs), with both N-terminus and C-terminus located in the cytoplasm[@pin2014]. Key structural features include:
Transmembrane Domains:
- 8 membrane-spanning α-helices
- Long extracellular loop between TM3 and TM4
- Histidine-rich region in the extracellular domain (potential zinc-binding)
Functional Domains:
- N-terminal variable region
- HExxH motif in TM4 (zinc transporter signature)
- C-terminal regulatory domain
ZIP transporters function as electroneutral symporters or antiporters, transporting zinc either with bicarbonate or in exchange for another ion. Unlike the ZnT (SLC30) family that exports zinc, ZIP transporters mediate zinc uptake into the cytoplasm.
Zinc homeostasis is tightly regulated through the coordinated action of ZIP and ZnT transporters[@kim2008]:
Zinc Uptake (ZIP family):
- ZIP1, ZIP2, ZIP3: High-affinity zinc uptake
- ZIP4: Intestinal zinc absorption
- ZIP8, ZIP10: Manganese and zinc transport
- ZIP11: Tissue-specific zinc uptake
Zinc Efflux (ZnT family):
- ZnT1: General zinc efflux
- ZnT2, ZnT3: Zinc sequestration
- ZnT4, ZnT5: Vesicular zinc transport
- ZnT6, ZnT7: Golgi zinc homeostasis
Zinc plays crucial roles in neuronal function[@Sekler2010][@nakanishi2011]:
Synaptic Zinc:
- Synaptic vesicles contain high zinc concentrations
- Released during neuronal activity
- Modulates NMDA receptor activity
- Influences synaptic plasticity
Intracellular Zinc:
- Cofactor for numerous enzymes
- Required for DNA binding by transcription factors
- Essential for protein structure and function
Zinc Signaling:
- Acts as a synaptic transmitter
- Modulates ion channel activity
- Participates in intracellular signaling cascades
Zinc dysregulation is a well-documented feature of AD pathogenesis[@adlard2010][@dChart2011]:
Amyloid Metabolism:
- Zinc binds to amyloid-β peptides
- Influences Aβ aggregation and plaque formation
- Modulates Aβ toxicity
Tau Pathology:
- Zinc affects tau phosphorylation
- Impacts microtubule stability
Synaptic Dysfunction:
- Zinc homeostasis critical for synaptic plasticity
- Dysregulation contributes to cognitive decline
Therapeutic Implications:
- Zinc supplementation trials in AD have yielded mixed results
- Targeted modulation of zinc transporters may be more effective
Zinc also plays roles in PD pathogenesis[@choi2020]:
Protein Aggregation:
- Zinc influences α-synuclein aggregation
- Modulates degradation pathways
Mitochondrial Function:
- Zinc is essential for mitochondrial enzymes
- Dysregulation contributes to energy failure
Neuroinflammation:
- Zinc modulates microglial activation
- Alters inflammatory responses
Therapeutic Potential:
- Zinc transporter modulators as PD therapeutics
- Zinc supplementation strategies under investigation
Zinc dysregulation is implicated in:
- Amyotrophic lateral sclerosis (ALS)
- Huntington's disease
- Multiple sclerosis
- Frontotemporal dementia
ZIP11 shows distinctive expression patterns[@kim2014][@kumar2019]:
High Expression:
- Testis (germ cells, Sertoli cells)
- Prostate (epithelial cells)
- Pancreas (islet cells)
Moderate Expression:
- Kidney
- Small intestine
- Liver
- Brain (lower levels)
Low/Variable Expression:
- Heart
- Lung
- Skeletal muscle
In the brain, ZIP11 expression is lower compared to other ZIP transporters (ZIP1, ZIP3, ZIP10). It may contribute to:
- Neuronal zinc uptake
- Glial cell zinc homeostasis
- Regional variation in zinc levels
ZIP11 localizes to:
- Plasma membrane
- Intracellular vesicles
- Endoplasmic reticulum (some reports)
ZIP11 likely interacts with:
Transport Partners:
- Carbonic anhydrases (for bicarbonate-dependent transport)
- Other zinc transporters (coordinate homeostasis)
Regulatory Proteins:
- Zinc sensors (MTF1)
- Transcription factors
- Post-translational modification enzymes
ZIP11 function relates to:
- Zinc-dependent signaling
- MTOR pathway (zinc-sensitive)
- p53 signaling (zinc-dependent)
- ROS response pathways
Zipl1 knockout mice (note: not ZIP11) show:
- Growth retardation
- Neurological deficits
- Impaired immunity
- Limited mouse knockout data
- Species-specific expression patterns
- Need for tissue-specific models
- Expression analysis (qPCR, RNA-seq)
- Promoter studies
- eQTL analysis
- Western blotting
- Immunofluorescence
- Surface biotinylation
- Zinc uptake assays
- Intracellular zinc measurements (FluoZin, fura-2)
- Transport kinetics
- Genetic association studies
- Biomarker development
- Therapeutic targeting
Targeting ZIP transporters for neurodegeneration:
Rationale:
- Zinc dysregulation is a common feature
- ZIP transporters are druggable targets
- Tissue-specific delivery possible
Strategies:
- Small molecule ZIP activators/inhibitors
- Gene therapy approaches
- Combination with zinc supplementation
- ZIP transporter redundancy
- Tissue-specific delivery
- Balancing zinc homeostasis
- Off-target effects
- What is the precise physiological role of ZIP11 in the brain?
- How does ZIP11 contribute to zinc dysregulation in neurodegeneration?
- Can ZIP11 be targeted therapeutically?
- What are the genetic variants affecting ZIP11 function?
- Single-cell expression analysis
- Structure-function studies
- In vivo imaging of zinc dynamics
- Therapeutic development
- Kim BE, et al, ZIP11 (SLC39A11): a zinc transporter expressed in the testis and prostate (2014)
- Pinilla J, et al, Solute carrier zinc transporters in cellular zinc homeostasis (2014)
- Liuzzi JP, et al, Zinc transporters, ZnT and ZIP gene families (2004)
- Kim JH, et al, ZIP family zinc transporters in neuronal function (2008)
- Chowanadisai W, et al, ZIP8 and ZIP10 in zinc homeostasis during development (2008)
- Luecke S, et al, ZIP10-mediated zinc uptake in neuronal cells (2010)
- Sekler I, et al, Zinc homeostasis in neuronal function (2010)
- Roth JA, et al, Cellular zinc metabolism and zinc signaling (2006)
- Freitas M, et al, Zinc transporters and neuroprotection (2010)
- DChart A, et al, Zinc dysregulation in neurodegenerative diseases (2011)
- Takeda A, et al, Zinc dynamics in synaptic function (2014)
- Nakanishi H, et al, Zinc signaling in the brain and neurological disease (2011)
- Adlard PA, et al, Zinc and Alzheimer's disease (2010)
- Cragin J, et al, ZIP transporters in zinc homeostasis and disease (2013)
- Hu Y, et al, ZIP11 expression in cancer and normal tissues (2018)
- Zhao L, et al, Zinc transporters in cognitive decline (2019)
- Choi J, et al, Role of zinc transporters in Parkinson's disease (2020)
- Kumar V, et al, ZIP11 promoter activity and tissue specificity (2019)
- Mittal R, et al, ZIP11 and zinc homeostasis in pancreatic cells (2017)
- Fujimura T, et al, ZIP11 and cellular zinc metabolism (2013)